Navigation Links
Study confirms recurrence of small-for-gestational-age pregnancies
Date:2/11/2013

In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in San Francisco, researchers will report findings that suggest women whose babies are small-for-gestational-age (SGA) in their first pregnancy have a strongly increased risk for SGA in a second pregnancy.

The aim of this study was to assess and describe in detail the incidence of SGA infants and the SGA recurrence rate in general. Additionally, it sought to assess the incidence and recurrence rate of SGA in women with and without a hypertensive disorder in their first pregnancy.

Infants who are small for gestational age (birth weight below the fifth percentile) are a heterogeneous group comprised of infants that have failed to achieve their growth potential (fetal growth restriction; FGR) and infants who are constitutionally small. SGA infants are at increased risk for perinatal mortality and adverse perinatal and health outcomes later in life.

"The main strength of this study was the size and composition of the cohort," said B J Voskamp, MD. "Data were derived from a large, well-maintained, population-based national perinatal registry."

The study was performed in a prospective nationwide cohort with the use of the Netherlands Perinatal Registry (PRN). The PRN consists of population-based data that includes information on pregnancy and delivery of 96 percent of pregnancies in the Netherlands. From this, they studied a cohort of women who delivered two subsequent singleton pregnancies (first and second deliveries) in the Netherlands from Jan. 1, 1999, through Dec. 31, 2007.

The primary outcome measure was SGA. Researchers registered demographic and obstetric characteristics including maternal age, parity, ethnicity, and socioeconomic status (SES).

Cases were analyzed in total and stratified into two groups: women with and without a hypertensive disorder in their first pregnancy. The analysis was stratified by gestational age at delivery in the first pregnancy in 3 groups: very preterm, late preterm, and full-term.

After exclusions, the study population was comprised of 259,481 women (518,962 deliveries). Five percent (12,943) of the women gave birth to SGA infants in their first pregnancy, and of those same women, SGA recurred in 2996 women (23.2 percent) in the subsequent pregnancy. SGA in the second pregnancy in women who had not previously had an SGA baby occurred in 3.4 percent of the women.

Further, the risk of SGA recurrence in women with hypertensive disorder in their first pregnancy was smaller than in women who did not. However, the risk of "de novo" SGA in the second pregnancy was higher for those with hypertensive disorder than their counterparts.


'/>"/>
Contact: Vicki Bendure
vicki@bendurepr.com
202-374-9259
Society for Maternal-Fetal Medicine
Source:Eurekalert

Related medicine news :

1. CWRU study suggests interacting with avatars may reduce depressive symptoms in young adults
2. Bel Marra Health Reports on a New Study: Mixed Weight Couples are More Likely to Have Unhappy Marriages
3. Infants Inattentiveness Might Signal Later Autism, Study Says
4. Dont Overlook Eating Issues Tied to Autism, Study Warns
5. Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study
6. Type 1 Diabetes Up 70 Percent in Kids, Study Finds
7. Pitt/UPMC team describes findings from BCI study in spinal cord-injured man in PLoS One
8. Study drug is first to help patients with recurrent low-grade ovarian cancer
9. One in Every 12 Stroke Survivors Contemplates Suicide, Study Finds
10. New study highlights Chagas disease as a growing health and socio-economic challenge
11. On-the-Job Stress Wont Raise Your Risk for Cancer, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: